Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.
about
Expression and function of RANK in human monocyte chemotaxisThe role of osteoprotegerin in arthritisA model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKLTumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivoAnimal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive ReviewRANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesBone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis.A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis.Methotrexate ameliorates pristane-induced arthritis by decreasing IFN-γ and IL-17A expressionsThe role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis.Effects of antibody to receptor activator of nuclear factor κ-B ligand on inflammation and cartilage degradation in collagen antibody-induced arthritis in mice.Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion.CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerinInfections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?Kcnn4 is a regulator of macrophage multinucleation in bone homeostasis and inflammatory diseaseCalcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis.Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand.RANK, RANKL and osteoprotegerin in arthritic bone loss.Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis.RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritisAnalysing the effect of novel therapies on cytokine expression in experimental arthritis.IKK{beta} as a target for treatment of inflammation induced bone loss.Rheumatic diseases: the effects of inflammation on bone.Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritisInhibition of RANKL as a treatment for osteoporosis: preclinical and early clinical studies.Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis.Mechanisms of Disease: the link between RANKL and arthritic bone disease.Novel host response therapeutic approaches to treat periodontal diseases.Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.Protective effect of curcumin on experimentally induced arthritic rats: detailed histopathological study of the joints and white blood cell count.Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells.Lymphocyte-derived cytokines in inflammatory arthritis.Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy.Adenovirus-mediated Foxp3 expression in lung epithelial cells reduces airway inflammation in ovalbumin and cockroach-induced asthma model.RANK/RANKL: regulators of immune responses and bone physiology.
P2860
Q24299177-03CF7A8C-6A76-4BC9-B44C-B6DE900AC27BQ24797889-A6BC624A-75B2-48E1-A237-103E28A581AFQ24799036-8A8BCD3F-E12D-4F62-A47F-452012ADD6D7Q24812465-517E2374-C10B-4B9E-B70A-A457CD37CFDCQ26774874-672D6E37-DDAD-4B91-89B4-2EF87253D38FQ28570898-B9E6B0E2-92F5-4677-87AF-B1BDAEF8DDEBQ33896725-C70FE431-7272-4D21-9475-A2E43CCD70C3Q34059280-56934D32-2566-445D-B3B7-802F84A851D8Q34413330-3737E2E7-311C-4095-9018-12EACF00E820Q34473197-DFC7B6DA-343A-4519-8037-2925A25CDD00Q34480349-42F0E3B3-BF8E-42AC-B9D3-421614179D46Q34746798-FEDE373C-BD18-4E54-BDE7-CD8C2A3952EBQ34974033-AC740CC1-60BE-422C-91E8-85C39D84440CQ35179608-775A4AC0-AA5A-4391-8AAC-02EE7EFE6AADQ35597152-0E06681E-17C3-434C-9F0D-D8CD9DCB3FF7Q35643989-2EE87163-A8BF-42FE-A916-A3038796692AQ35754345-8E2DCCB4-6048-434A-8DEF-0B7B72727901Q35781391-9EB57A72-120D-4C84-ABE6-3CDB6446E101Q36045625-288118AD-BCF3-4BF0-829D-42908239720CQ36078073-F66B51AA-8E21-417B-A363-9C3033996EB2Q36228311-5B8A8910-9542-4750-8DA3-642D840E7282Q36246148-88552F2C-6A7C-4E21-AC94-B4BE3DC94576Q36271120-8BFD256A-021E-413C-B193-BDF01AB2F610Q36292663-0076268A-0E71-4981-96B3-9D57646EAEA0Q36324975-4317A12A-9D0E-4391-97A0-A123855F438AQ36326701-69C0EE54-228D-43CC-B868-83BD4AC809E7Q36417317-B8BAABD7-5745-48B4-AA80-CCBF9EC8EB01Q36518539-FDD3BCD1-8A35-4A69-B042-88F3B2147C38Q36577375-21FF4DCE-86C7-4DB4-84D0-0AA8F7094172Q36703987-D06DDB52-908D-4BDD-854B-6DD34E2D9EA4Q36769636-40E2FC55-6CB5-4DDE-AE60-5A72D2356B95Q36860987-565FA1F2-6520-464E-9215-61FB238FAF15Q36973041-0DA6ADED-6CA7-4CFA-AF80-1A8E4C9FF213Q37054188-F41B41E0-22AA-4044-A8FA-D75283E63908Q37107080-B61E2832-EC90-40B9-A354-E9E8C369EA67Q37118786-90347C3A-3787-42F7-90B7-8FF9DC909184Q37300823-FA122F7B-CDB5-4F37-851A-35C4374AE6C9Q37307876-1EAEE87C-8D7D-4D1D-AFBA-6FC3FF6D4C13Q37310251-F6D87A0F-865C-4A2F-AEA2-A45BCE915AFAQ37348448-D124184B-8A0D-41AC-B7A5-A369D90BD3FB
P2860
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Osteoprotegerin reduces osteoc ...... in collagen-induced arthritis.
@ast
Osteoprotegerin reduces osteoc ...... in collagen-induced arthritis.
@en
type
label
Osteoprotegerin reduces osteoc ...... in collagen-induced arthritis.
@ast
Osteoprotegerin reduces osteoc ...... in collagen-induced arthritis.
@en
prefLabel
Osteoprotegerin reduces osteoc ...... in collagen-induced arthritis.
@ast
Osteoprotegerin reduces osteoc ...... in collagen-induced arthritis.
@en
P2093
P2860
P1476
Osteoprotegerin reduces osteoc ...... in collagen-induced arthritis.
@en
P2093
Daphne K Hards
Evan Romas
Julian W M Quinn
Mandy Lindsay
Matthew T Gillespie
Natalie A Sims
Peter F J Ryan
T John Martin
P2860
P304
P356
10.1016/S0002-9440(10)64417-3
P407
P577
2002-10-01T00:00:00Z